AAAAAA

   
Results: 1-18 |
Results: 18
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY FOR THE QUANTIFICATION OF NORTRIPTYLINE AND 10-HYDROXYNORTRIPTYLINE IN PLASMA
Authors: TYBRING G NORDIN J WIDEN J
Citation: G. Tybring et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY FOR THE QUANTIFICATION OF NORTRIPTYLINE AND 10-HYDROXYNORTRIPTYLINE IN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 382-386
CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION
Authors: SAGAR M SEENSALU R TYBRING G DAHL ML BERTILSSON L
Citation: M. Sagar et al., CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION, Scandinavian journal of gastroenterology, 33(10), 1998, pp. 1034-1038
CORRELATION BETWEEN STEADY-STATE PLASMA-CONCENTRATIONS OF MIANSERIN AND TRAZODONE IN DEPRESSED-PATIENTS
Authors: OTANI K TYBRING G MIHARA K YASUI N KANEKO S OHKUBO T NAGASAKI T SUGAWARA K
Citation: K. Otani et al., CORRELATION BETWEEN STEADY-STATE PLASMA-CONCENTRATIONS OF MIANSERIN AND TRAZODONE IN DEPRESSED-PATIENTS, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 347-349
THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE
Authors: SAGAR M TYBRING G DAHL ML BERTILSSON L SEENSALU R
Citation: M. Sagar et al., THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE, Gastroenterology, 114(4), 1998, pp. 1122-1122
PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES
Authors: YUE QY ZHONG ZH TYBRING G DALEN P DAHL ML BERTILSSON L SJOQVIST F
Citation: Qy. Yue et al., PHARMACOKINETICS OF NORTRIPTYLINE AND ITS 10-HYDROXY METABOLITE IN CHINESE SUBJECTS OF DIFFERENT CYP2D6 GENOTYPES, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 384-390
BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE
Authors: HERRLIN K MASSELE AY JANDE M ALM C TYBRING G ABDI YA WENNERHOLM A JOHANSSON I DAHL ML BERTILSSON L GUSTAFSSON LL
Citation: K. Herrlin et al., BANTU TANZANIANS HAVE A DECREASED CAPACITY TO METABOLIZE OMEPRAZOLE AND MEPHENYTOIN IN RELATION TO THEIR CYP2C19 GENOTYPE, Clinical pharmacology and therapeutics, 64(4), 1998, pp. 391-401
EFFECTS OF THIORIDAZINE, AN INHIBITOR OF CYP2D6, ON THE STEADY-STATE PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND ITS ACTIVE METABOLITE, DESMETHYLMIANSERIN, IN DEPRESSED JAPANESE PATIENTS
Authors: YASUI N TYBRING G OTANI K MIHARA K SUZUKI A SVENSSON JO KANEKO S
Citation: N. Yasui et al., EFFECTS OF THIORIDAZINE, AN INHIBITOR OF CYP2D6, ON THE STEADY-STATE PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF MIANSERIN AND ITS ACTIVE METABOLITE, DESMETHYLMIANSERIN, IN DEPRESSED JAPANESE PATIENTS, Pharmacogenetics, 7(5), 1997, pp. 369-374
CARBAMAZEPINE TREATMENT INDUCES THE CYP3A4 CATALYZED SULFOXIDATION OFOMEPRAZOLE, BUT HAS NO OR LESS EFFECT ON HYDROXYLATION VIA CYP2C19
Authors: BERTILSSON L TYBRING G WIDEN J CHANG M TOMSON T
Citation: L. Bertilsson et al., CARBAMAZEPINE TREATMENT INDUCES THE CYP3A4 CATALYZED SULFOXIDATION OFOMEPRAZOLE, BUT HAS NO OR LESS EFFECT ON HYDROXYLATION VIA CYP2C19, British journal of clinical pharmacology, 44(2), 1997, pp. 186-189
THE CYP2D6 GENOTYPE AND PLASMA-CONCENTRATIONS OF MIANSERIN ENANTIOMERS IN RELATION TO THERAPEUTIC RESPONSE TO MIANSERIN IN DEPRESSED JAPANESE PATIENTS
Authors: MIHARA K OTANI K TYBRING G DAHL ML BERTILSSON L KANEKO S
Citation: K. Mihara et al., THE CYP2D6 GENOTYPE AND PLASMA-CONCENTRATIONS OF MIANSERIN ENANTIOMERS IN RELATION TO THERAPEUTIC RESPONSE TO MIANSERIN IN DEPRESSED JAPANESE PATIENTS, Journal of clinical psychopharmacology, 17(6), 1997, pp. 467-471
INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION
Authors: SAGAR M BERTILSSON L DAHL ML TYBRING G SEENSALU R
Citation: M. Sagar et al., INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 275-275
INHIBITION OF THE SULFOXIDATION OF OMEPRAZOLE BY KETOCONAZOLE IN POORAND EXTENSIVE METABOLIZERS OF S-MEPHENYTOIN
Authors: BOTTIGER Y TYBRING G GOTHARSON E BERTILSSON L
Citation: Y. Bottiger et al., INHIBITION OF THE SULFOXIDATION OF OMEPRAZOLE BY KETOCONAZOLE IN POORAND EXTENSIVE METABOLIZERS OF S-MEPHENYTOIN, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 384-391
ENANTIOSELECTIVE HYDROXYLATION OF OMEPRAZOLE CATALYZED BY CYP2C19 IN SWEDISH WHITE SUBJECTS
Authors: TYBRING G BOTTIGER Y WIDEN J BERTILSSON L
Citation: G. Tybring et al., ENANTIOSELECTIVE HYDROXYLATION OF OMEPRAZOLE CATALYZED BY CYP2C19 IN SWEDISH WHITE SUBJECTS, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 129-137
PHARMACOGENETICS OF ANTIDEPRESSANTS - CLINICAL ASPECTS
Authors: BERTILSSON L DAHL ML TYBRING G
Citation: L. Bertilsson et al., PHARMACOGENETICS OF ANTIDEPRESSANTS - CLINICAL ASPECTS, Acta psychiatrica Scandinavica, 96, 1997, pp. 14-21
CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED BY OMEPRAZOLE IN A KOREAN POPULATION
Authors: ROH HK DAHL ML TYBRING G YAMADA H CHA YN BERTILSSON L
Citation: Hk. Roh et al., CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED BY OMEPRAZOLE IN A KOREAN POPULATION, Pharmacogenetics, 6(6), 1996, pp. 547-551
USE OF OMEPRAZOLE AS A PROBE DRUG FOR CYP2C19 PHENOTYPE IN SWEDISH CAUCASIANS - COMPARISON WITH S-MEPHENYTOIN HYDROXYLATION PHENOTYPE AND CYP2C19 GENOTYPE
Authors: CHANG M DAHL ML TYBRING G GOTHARSON E BERTILSSON L
Citation: M. Chang et al., USE OF OMEPRAZOLE AS A PROBE DRUG FOR CYP2C19 PHENOTYPE IN SWEDISH CAUCASIANS - COMPARISON WITH S-MEPHENYTOIN HYDROXYLATION PHENOTYPE AND CYP2C19 GENOTYPE, Pharmacogenetics, 5(6), 1995, pp. 358-363
INTERPHENOTYPE DIFFERENCES IN DISPOSITION AND EFFECT ON GASTRIN-LEVELS OF OMEPRAZOLE - SUITABILITY OF OMEPRAZOLE AS A PROBE FOR CYP2C19
Authors: CHANG M TYBRING G DAHL ML GOTHARSON E SAGAR M SEENSALU R BERTILSSON L
Citation: M. Chang et al., INTERPHENOTYPE DIFFERENCES IN DISPOSITION AND EFFECT ON GASTRIN-LEVELS OF OMEPRAZOLE - SUITABILITY OF OMEPRAZOLE AS A PROBE FOR CYP2C19, British journal of clinical pharmacology, 39(5), 1995, pp. 511-518
ENANTIOSELECTIVE DETERMINATION OF MIANSERIN AND ITS DESMETHYL METABOLITE IN PLASMA DURING TREATMENT OF DEPRESSED JAPANESE PATIENTS
Authors: TYBRING G OTANI K KANEKO S MIHARA K FUKUSHIMA Y BERTILSSON L
Citation: G. Tybring et al., ENANTIOSELECTIVE DETERMINATION OF MIANSERIN AND ITS DESMETHYL METABOLITE IN PLASMA DURING TREATMENT OF DEPRESSED JAPANESE PATIENTS, Therapeutic drug monitoring, 17(5), 1995, pp. 516-521
STEREOSELECTIVE DISPOSITION OF MIANSERIN IS RELATED TO DEBRISOQUIN HYDROXYLATION POLYMORPHISM
Authors: DAHL ML TYBRING G ELWIN CE ALM C ANDREASSON K GYLLENPALM M BERTILSSON L
Citation: Ml. Dahl et al., STEREOSELECTIVE DISPOSITION OF MIANSERIN IS RELATED TO DEBRISOQUIN HYDROXYLATION POLYMORPHISM, Clinical pharmacology and therapeutics, 56(2), 1994, pp. 176-183
Risultati: 1-18 |